TWiV 867: I love the smell of vaccines in the morning

February 17, 2022

TWiV reviews an experimental, intranasally administered SARS-CoV-2 vaccine that utilizes adenovirus vectors to deliver three viral proteins and induces immunity to ancestral and variant isolates.

Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Kathy Spindler

Click arrow to play
Download TWiV 867 (128 MB .mp3, 107 min)
Subscribe (free): Apple PodcastsGoogle PodcastsRSSemail

Become a patron of TWiV!

Weekly Picks 1:29:40

Kathy 477-mile-long megaflash lightning in Seattle Times (originally Washington Post) and extra info from Rich World Meteorological Org
RichNIAID Global Research (Mali)
Alan – New method for recycling electric car batteries
Vincent Q&A with A&V

Listener Picks

AddieVaccine Podcast
JennieDr. Katelyn Jetelina, aka Your Local Epidemiologist

Intro music is by Ronald Jenkees

Send your virology questions and comments to

Leave a Reply

Your email address will not be published. Required fields are marked *

6 comments on “TWiV 867: I love the smell of vaccines in the morning

  1. Lisa McConlogue Feb 20, 2022

    The experimental mice in the paper discussed in this episode almost certainly would’ve had prior exposure to human adenovirus via their caretakers. They would be very unlikely to have had prior exposure to chimpanzee adenovirus virus. I’m wondering how this would have affected the results in the paper.